Doctors often suspect C. difficile in anyone with diarrhea who has taken antibiotics within the past two months or when diarrhea develops a few days after hospitalization. In such cases, you're likely to have one or more of the following tests.
Toxins produced by C. difficile bacteria can usually be detected in a sample of your stool. Several main types of lab tests exist, and they include:
- Enzyme immunoassay. The enzyme immunoassay (EIA) test is faster than other tests but isn't sensitive enough to detect many infections and has a higher rate of falsely normal tests.
- Polymerase chain reaction. This sensitive molecular test can rapidly detect the C. difficile toxin B gene in a stool sample and is highly accurate.
- GDH/EIA. Some hospitals use a glutamate dehydrogenase (GDH) in conjuction with an EIA test. GDH is a very sensitive assay and can accurately rule out the presence of C. difficile in stool samples.
- Cell cytotoxicity assay. A cytotoxicity test looks for the effects of the C. difficile toxin on human cells grown in a culture. This type of test is sensitive, but it is less widely available, more cumbersome to do and requires 24 to 48 hours for test results. Some hospitals use both the EIA test and cell cytotoxicity assay to ensure accurate results.
Testing for C. difficile is unnecessary if you're not having diarrhea or watery stools, and is not helpful for follow-up treatment.
In rare instances, to help confirm a diagnosis of C. difficile infection and look for alternatives, your doctor may examine the inside of your colon. This test (flexible sigmoidoscopy or colonoscopy) involves inserting a flexible tube with a small camera on one end into your colon to look for areas of inflammation and pseudomembranes.
If your doctor is concerned about possible complications of C. difficile, he or she may order an abdominal X-ray or a computerized tomography (CT) scan, which provides images of your colon. The scan can detect the presence of complications such as thickening of the colon wall, expanding of the bowel, or more rarely, a hole (perforation) in the lining of your colon.
June 18, 2016
- Clostridium difficile-induced diarrhea. Merck Manual Professional Version. http://www.merckmanuals.com/professional/infectious-diseases/anaerobic-bacteria/clostridium-difficile-–induced-diarrhea. Accessed Feb. 5, 2016.
- Longo DL, et al., eds. Clostridium difficile infection, including pseudomembranous colitis. In: Harrison's Principles of Internal Medicine. 19th ed. New York, N.Y.: McGraw-Hill Education; 2015. http://accessmedicine.com. Accessed Feb. 5, 2016.
- Cammarota G, et al. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: A systematic review. Journal of Clinical Gastroenterology. 2014;48:693.
- Waltz P, et al. Novel therapies for severe Clostridium difficile colitis. Current Opinion in Critical Care. In press. Accessed Feb. 8, 2016.
- Malani PN, et al. Expanded evidence for frozen fecal microbiota transplantation for Clostridium difficile infection: A fresh take. JAMA. 2016;315:137.
- LaMont JT. Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology. http://www.uptodate.com/home. Accessed Feb. 8, 2016.
- Kelly CP, et al. Clostridium difficile in adults: Treatment. http://www.uptodate.com/home. Accessed Feb. 8, 2016.
- Frequently asked questions about Clostridium difficile for healthcare providers. Centers for Disease Control and Prevention. http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_faqs_HCP.html. Accessed Feb. 8, 2016.
- LaMont JT. Clostridium difficile in adults: Clinical manifestations and diagnosis. http://www.uptodate.com/home. Accessed Feb. 8, 2016.
- Surawicz CM, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. The American Journal of Gastroenterology. 2013;108:478.
- Davidson LE, et al. Clostridium difficile and probiotics. http://www.uptodate.com/home. Accessed Feb. 9, 2016.
- Khanna S (expert opinion). Mayo Clinic, Rochester, Minnesota. Feb. 16, 2016.